The introduction of innovative ED devices is fuelling the growth of the global erectile dysfunction market.
Arizton’s recent market research report on the erectile dysfunction market identifies Bayer AG, Eli Lilly and Company, VIVUS, Inc, Pfizer, Boston Scientific Corp., and Coloplast A/S as the leading vendors that are likely to dominate the market during the forecast period. This research report provides a detailed analysis of market segmentation by therapy type (drug therapies and device therapies) and geography (APAC, Europe, Latin America, MEA, and North America).
The global erectile dysfunction market is expected to generate revenue of $4,249.07 million during the forecast period.
The global erectile dysfunction market is categorized into the following segments by therapy type and by geography.
The erectile dysfunction market by therapy type is segmented into drug and device therapy.
The devices therapy segment was valued at $522.00 million in 2017 and is anticipated to grow at a CAGR of 3.60% during the forecast period.
The growing preferability of non-invasive devices and increase in minimally invasive implant surgeries is driving the growth of the global erectile dysfunction devices market. The erectile dysfunction devices market is further categorized into vacuum erection devices, penile implants, and other penile prosthesis and devices. Penile implants dominated the erectile dysfunction devices market, accounting for close to 47% of the total market share in 2017. Penile implants are the widely available treatment modality in the global market. These implants are usually the last line of therapy that has the potential to cure the disease. The advances in prosthesis design, device technologies, and surgical techniques will make penile prosthesis implant natural, durable, and reliable devices in the global market. The development and introduction of the advanced penile prosthesis will drive the growth of the erectile dysfunction devices market during the forecast period.
The erectile dysfunction market by geography is classified into APAC, Europe, Latin America, MEA, and North America. APAC is the fastest growing region in the global erectile dysfunction market at a CAGR of 3.38% and is expected to reach the revenue of $910.27 million during the forecast period. The wide availability of low-cost generic drugs and the high prevalence of ED in the region are driving the growth of the erectile dysfunction market in APAC. Countries such as India, China, Japan, and Australia are the highest revenue contributors in the erectile dysfunction market in APAC. Launch of awareness campaigns, increased interests on sexual well-being, increase in disposable income, and availability of low-cost generic ED medications are some of the primary factors augmenting the growth of the global erectile dysfunction market. Moreover, leading vendors are increasing their investments to expand their businesses in the APAC region and commercialize the drugs and device therapeutics in the region.
Apricus Biosciences Inc, Endo International plc, Futura Medical, Premedon, Teva Pharmaceutical Industries Limited (Teva), Zephyr Surgical Implants (ZSI), Augusta Medical Systems LLC (Augusta Medical), Post-T-Vac Medical, Bonro Medical, Cristalia Produtos Quimicos Farmaceuticos Ltd, and SK Chemicals are the other prominent vendors in the global erectile dysfunction market.
The complete overview of the latest market research report on the erectile dysfunction market by Arizton is now available.
The report offers a detailed study of major trends, drivers, challenges, and provides the market size and forecast for major geographical regions and key countries.
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.
We offer comprehensive market research reports on industries such as consumer goods & retail technology, automotive and mobility, smart tech, healthcare and life sciences, industrial machinery, chemicals and materials, IT and media, logistics and packaging. These reports contain detailed industry analysis, market size, share, growth drivers, and trend forecasts.
Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.